epocrates: Drug Info & Pill ID vs Glycemic Index Guide Tracker
A data-backed head-to-head — estimated revenue, downloads, ratings and pricing side by side, from live App Store signals. Updated continuously.
Revenue / mo
$140k–$790k
$30–$200
Downloads / mo
280k–1.2M
50–300
Rating
★ 4.44 (7k)
★ 4.40 (43)
Pricing
Free + IAP
Free + IAP
Category
Medical
Medical
Released
7.5y ago
1.6y ago
Verdict: epocrates: Drug Info & Pill ID earns more — an estimated $140k–$790k/mo, versus $30–$200/mo for Glycemic Index Guide Tracker.